Saudi Arabia’s food and drug administration has approved the Covid vaccine made by AstraZeneca.
The SFDA gave clearance for the administration of the jab based on data provided by the
manufacturers, but will test the vaccine once they receive the shipments, the Saudi Press Agency reported.
Health Ministry spokesman Dr. Mohammed Al-Abdulaali said: “We have exceeded half-a-million doses of the coronavirus vaccine, and the plan to expand continues to accelerate.”
He added that the National Committee for Infectious Diseases has approved one dose for those who have previously been infected with the virus six months on from their recovery.
#SFDA allows the use of AstraZeneca #Covid19 vaccine to be the second vaccine in the country. pic.twitter.com/8ngHi9YSGk
— Saudi Food & Drug Authority (@Saudi_fda_en) February 18, 2021
The dose, he said, is considered a booster for the natural immunity that they have formed, and the health status in Tawakkalna app will be “immune-recovered.”
He also stressed that vaccines are a strong weapon to combat the pandemic and that all vaccines given in the Kingdom are safe and effective.
The country’s Ministry of Health has begun the mass vaccination campaign against coronavirus at the Umm Al-Qura University Vaccination Center in Al-Abdiyah, Makkah on Tuesday.
Hamad Al-Otaibi, spokesman of health affairs in Makkah region, said that the gradual operation of the vaccination center at Umm Al-Qura University has started, through six tracks with a capacity for 4,000 people.
Al-Otaibi said that the Umm Al-Qura University Vaccination Center is the main vaccination center in Makkah, and five other centers will be opened soon.
The Kingdom launched its coronavirus vaccination campaign on December 17, 2020, after receiving its first shipment of the Pfizer-BioNTech vaccine in an effort to control the outbreak.
Saudi Arabia is the second country in the Gulf Cooperation Council, after Bahrain, to use the Pfizer-BioNTech vaccine.
Saudi Arabia’s coronavirus death toll now stands at 6,450.
